Research Article
Abnormal differentiation of memory T cells in systemic lupus erythematosus
Ruth D. Fritsch, Xinglei Shen, Gabor G. Illei, Cheryl H. Yarboro, Calman Prussin, Karen S. Hathcock, Richard J. Hodes, Peter E. Lipsky,
Corresponding Author
Peter E. Lipsky
NIH, Bethesda, Maryland
NIAMS, NIH, Building 10, Room 6D47C, 9000 Rockville Pike, Bethesda, MD 20892Search for more papers by this authorRuth D. Fritsch, Xinglei Shen, Gabor G. Illei, Cheryl H. Yarboro, Calman Prussin, Karen S. Hathcock, Richard J. Hodes, Peter E. Lipsky,
Corresponding Author
Peter E. Lipsky
NIH, Bethesda, Maryland
NIAMS, NIH, Building 10, Room 6D47C, 9000 Rockville Pike, Bethesda, MD 20892Search for more papers by this authorAbstract
Objective
The chemokine receptor CCR7 and the tumor necrosis factor receptor family member CD27 define 3 distinct, progressively more differentiated maturational stages of CD4 memory subpopulations in healthy individuals: the CCR7+,CD27+, the CCR7−, CD27+, and the CCR7−,CD27− populations. The goal of this study was to examine maturational disturbances in CD4 T cell differentiation in systemic lupus erythematosus (SLE), using these phenotypic markers.
Methods
Phenotypic analysis by flow cytometry, in vitro stimulation experiments, telomere length measurement, and determination of inducible telomerase were carried out.
Results
In SLE patients, significant increases of CCR7−,CD27− and CCR7−,CD27+ and a reduction of CCR7+,CD27+ CD4 memory T cells were found. In vitro stimulation of SLE T cells showed a stepwise differentiation from naive to CCR7+,CD27+ to CCR7−,CD27+ to CCR7−,CD27−; telomere length and inducible telomerase decreased in these subsets in the same progressive sequence. The in vitro proliferative response of these populations progressively declined as their susceptibility to apoptosis increased. Interestingly, a significant reduction in inducible telomerase was noted in SLE naive and CCR7+,CD27+ CD4+ memory T cells. Additionally, SLE CCR7−,CD27+ and CCR7−, CD27− CD4 memory T cells proliferated poorly in response to in vitro stimulation and underwent significantly more apoptosis than their normal counterparts. Finally, expression of CXCR4 was significantly reduced in all SLE subsets compared with normal.
Conclusion
Together these data indicate an increased degree of in vivo T cell stimulation in SLE, resulting in the accumulation of terminally differentiated memory T cells with a decreased proliferative capacity and an increased tendency to undergo apoptosis upon stimulation.
REFERENCES
- 1 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7.
- 2 Tsokos GC, Nambiar MP, Tenbrock K, Yuang-Taung J. Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE [review]. Trends Immunol 2003; 24: 259–63.
- 3 Kong PL, Odegard JM, Bouzahzah F, Choi JY, Eardley LD, Zielinski CE, et al. Intrinsic T cell defects in systemic autoimmunity [review]. Ann N Y Acad Sci 2003; 987: 60–7.
- 4 Gordon C, Matthews N, Schlesinger BC, Akbar AN, Bacon PA, Emery P, et al. Active systemic lupus erythematosus is associated with the recruitment of naive/resting T cells. Br J Rheumatol 1996; 35: 226–30.
- 5 Neidhart M, Pataki F, Michel BA, Fehr K. CD45 isoforms expression on CD4+ and CD8+ peripheral blood T-lymphocytes is related to auto-immune processes and hematological manifestations in systemic lupus erythematosus. Schweiz Med Wochenschr 1996; 126: 1922–5.
- 6 Vassilopoulos D, Kovacs B, Tsokos GC. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J Immunol 1995; 155: 2269–81.
- 7 Krishnan S, Farber DL, Tsokos GC. T cell rewiring in differentiation and disease. J Immunol 2003; 171: 3325–31.
- 8 Katsiari CG, Kyttaris VC, Juang YT, Tsokos GC. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J Clin Invest 2005; 115: 3193–204.
- 9 Fritsch RF, Shen X, Hathcock KS, Hodes RJ, Lipsky PE. Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol 2005; 175: 6489–97.
- 10 Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing and effector functions. Nature 1999; 401: 708–12.
- 11 Baekkevold ES, Yamanaka T, Palframan RT, Carlsen HS, Reinholt FP, von Andrian UH, et al. The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med 2001; 193: 1105–12.
- 12 Tanabe S, Lu Z, Luo Y, Quackenbush EJ, Berman MA, Collins-Racie LA, et al. Identification of a new mouse β-chemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells. J Immunol 1997; 159: 5671–9.
- 13 Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T cells. Proc Natl Acad Sci U S A 1998; 95: 258–63.
- 14 Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291: 2413–7.
- 15 Van Lier RAW, Borst J, Vroom TM, Klein H, van Mourik P, Zeijlemaker WP, et al. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol 1987; 139: 1589–96.
- 16 Hintzen RQ, de Jong R, Lens SM, Brouwer M, Baars P, van Lier RA. Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol 1993; 151: 2426–30.
- 17 Tortorella C, Schulze-Koops H, Thomas R, Splawski JB, Davis LS, Picker LJ, et al. Expression of CD45RB and CD27 identifies subsets of CD4+ memory T cells with different capacities to induce B cell differentiation. J Immunol 1995; 155: 149–62.
- 18 Hintzen RQ, Jong J, Lens SM, van Lier RA. CD27: marker and mediator of T-cell activation. Immunol Today 1994; 15: 307–11.
- 19 De Jong R, Brouwer M, Hooibrink B, van der Pouw-Kraan T, Miedema F, van Lier RA. The CD27- subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur J Immunol 1992; 22: 993–9.
- 20 Nijhuis EW, Remarque EB, Hinloopen B, van der Pouw-Kraan T, van Lier RA, Ligthart GJ, et al. Age related increase in the fraction of CD27-CD4+ T cells and IL-4 production as a feature of CD4+ T cell differentiation in vivo. Clin Exp Immunol 1994; 96: 528–34.
- 21 Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–40.
- 22 Hathcock KS, Hodes RJ, Weng NP. Analysis of telomere length and telomerase activity. In: JE Coligan, AM Kruisbeck, DH Margulies, EM Shevach, W Strober, editors. Current protocols in immunology. New York: Greene Publishing Associates and Wiley-Interscience; 2004. p. 10.30.1–27.
- 23 Kimming S, Przybylski GK, Schmidt CA, Laurisch K, Mowes B, Radbruch A, et al. Two subsets of naive T helper cells with a distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002; 195: 789–794.
- 24 Amyes E, Hatton C, Montamat-Sicotte D, Gudgeon N, Rickinson AB, McMichael AJ, et al. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med 2003; 198: 903–911.
- 25 Langenkamp A, Nagata K, Murphy K, Wu L, Lanzavecchia A, Sallusto F. Kinetics and expression patterns of chemokine receptors in human CD4+ T lymphocytes primed by myeloid or plasmacytoid dendritic cells. Eur J Immunol 2003; 33: 474–82.
- 26 Emlen W, Niebur JA, Adera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152: 3685–92.
- 27 Silvestris S, Grinello D, Tucci M, Cafforio P, Dammaco F. Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95-Apo-I) in active lupus. Lupus 2003; 12: 8–14.
- 28 Kurosaka D, Yasuda J, Yoshida K, Yokoyama T, Ozawa Y, Obayashi Y, et al. Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients. Lupus 2003; 12: 591–9.
- 29 Honda M, Mengesha E, Albano S, Nichols WS, Wallace DJ, Metzger A, et al. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28 (lo) T cells in patients with systemic lupus erythematosus. Clin Immunol 2001; 99: 211–21.
- 30 Klapper W, Moosig F, Sotnikova A, Qian W, Schroder JO, Parwaresch R. Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1681–3.
- 31 Weng NP, Palmer LD, Levine BL, Lane HC, June CH, Hodes RJ. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 1997; 160: 43–54.
- 32 Buchkovich KB, Greider CW. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 1996; 7: 1443–54.
- 33 Weng N, Levine BL, June CH, Hodes RJ. Regulation of telomerase RNA template expression in human T lymphocyte development and activation. J Immunol 1997; 158: 3215–20.
- 34 Thiel A, Schmitz J, Miltenyi S, Radbruch A. CD45RA-expressing memory/effector Th cells committed to production of interferon lack expression of CD31. Immunol Lett 1997; 57: 189–92.
- 35 Nath SK, Namjou B, Garriott CP, Frank S, Joslin PA, Kilpatrick J, et al. Linkage analysis of SLE susceptibility: confirmation of SLER1 at 5p15.3. Genes Immun 2004; 5: 209–14.
- 36 Aringer M, Stummvoll GH, Steiner G, Koller M, Steiner CW, Hofler E, et al. Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology (Oxford) 2001; 40: 876–81.
- 37 Akiyama M, Yamada O, Hideshima T, Yanagisawa T, Yokoi K, Fujisawa K, et al. TNFα induces rapid activation and nuclear translocation of telomerase in human lymphocytes. Biochem Biophys Res Commun 2004; 316: 528–32.
- 38 Rivino L, Messi M, Jarrossay D, Lanzavecchia A, Sallusto F, Geginat J. Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J Exp Med 2004; 200: 725–35.
- 39 Nanki T, Lipsky PE. Lack of correlation between chemokine receptor and T(h)1/T(h)2 cytokine expression by individual memory T cells. Int Immunol 2000; 12: 1659–67.
- 40
Bermejo M,
Martin-Serrano J,
Oberlin E,
Pedraza MA,
Serrano A,
Santiago B, et al.
Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains.
Eur J Immunol
1998;
28:
3192–204.
10.1002/(SICI)1521-4141(199810)28:10<3192::AID-IMMU3192>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- 41 Eriksson C, Eneslatt K, Ivanoff J, Rantapaa-Dahlqvist S, Sundqvist KG. Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus. Lupus 2003; 12: 766–74.
- 42 Signoret N, Oldrige J, Pelchen-Matthews A, Klasse PJ, Tran T, Brass LF, et al. Phorbol esters and SDF-1 induce rapid endocytosis and down-modulation of the chemokine receptor CXCR4. J Cell Biol 1997; 139: 651–664.
